Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This trial found that intradermal injections of the Hair Stimulating Complex were well-tolerated and effectively stimulated hair growth and prevented hair loss in male pattern baldness participants over 18 weeks.

This review discusses genetic factors and associated diseases linked to androgenetic alopecia but reports no new clinical findings.

This study of androgenic alopecia patients reports that stress was associated with AGA in both men and women, with notable findings differing by gender, age, and AGA type.

In this study, researchers found that stress is linked to androgenic alopecia in both male and female patients, with an increasing number of female patients in their forties experiencing the condition.

This study observed that Taiwanese men aged 40–91 who smoked 20 or more cigarettes daily had a higher incidence of moderate to severe androgenetic alopecia.

This study found that among Korean patients with androgenetic alopecia, a significant portion had a family history, and pelvic ultrasound showed increased rates of abnormalities in female patients, although not recommended as a routine test.

This study found that androgenetic alopecia in Koreans is associated with family history and increased androgen levels, with Norwood class IIIv most common in males and Ludwig class I in females.

In this study conducted at Saveetha Dental College, researchers found that the severity of male androgenetic alopecia, as graded by Norwood's classification, increased with age, although other factors such as genetic or hormonal influences were not assessed.

This letter discusses how severe baldness in men is associated with higher risk of severe COVID-19, and highlights research suggesting antiandrogen medications may improve outcomes.

In this case report, a 38-year-old male with androgenetic alopecia showed increased hair density and reduced follicular miniaturization after receiving UC-MSCs derived secretome injections, suggesting potential effectiveness and safety for hair restoration; further research is needed for broader validation.

This study suggests that a high frequency of androgenetic alopecia is associated with increased severity of COVID-19 in hospitalized patients.

This study suggests that Botox injections may increase hair count and reduce hair loss in men with androgenetic alopecia, potentially through increased blood flow and oxygen to the scalp.

This review discusses various classification systems for male-pattern hair loss, comparing their detail, practicality, and reproducibility, and reports no new clinical outcomes.

This study found that a high proportion of androgenetic alopecia patients were young individuals with mild types, potentially due to psychological stress in social situations.

This study found that trained observers using the Hamilton-Norwood classification were very reliable in assessing balding patterns, while men's self-assessments were moderately accurate compared to observers.

This study observed an increasing trend of young patients with androgenetic alopecia visiting dermatologists, with genetic factors and abnormal androgen metabolism in the scalp contributing to its development.

This case report describes a 47-year-old male with advanced androgenic alopecia who had a cosmetically acceptable forelock growth after a hair restoration session using chest hair.

This study reported an increase in female androgenic alopecia patients in their forties and found stress-related factors, particularly work tasks, associated with AGA in both male and female patients.

This study reports that the prevalence of male pattern baldness in Asians is higher than previously believed, with potential links to socioeconomic factors and westernized diets, though the exact cause remains unclear.

This article discusses the use of cetuximab for recurrent squamous cell skin cancer in palliative care, noting good responses but frequent cutaneous side effects; it presents no new findings.

This study concluded that visits to emergency and urgent care centers for severe sunburn treatment are largely avoidable and contribute to significant healthcare costs.

Hair transplantation is a surgical procedure to move hair to bald areas, requires good donor hair, and results show in about a year.

Botulinum toxin injections can reduce hair loss and stimulate new hair growth in some men with male pattern baldness.

In this study, platelet rich plasma treatment showed efficacy in improving hair count, thickness, and density in male patients with androgenetic alopecia.

In this study, the Hamilton-Norwood subtype of female pattern hair loss was associated with early onset and polycystic ovary syndrome, while the Ludwig pattern was more common overall.

This study found that men with X-linked recessive ichthyosis did not show mutual exclusivity with androgenetic alopecia, as some exhibited advanced hair loss.

This review discusses the scalp and follicular microbiome's potential role in hair diseases and the emerging interest in microbiome-targeted therapies, but reports no new clinical findings.

This study found no relationship between androgenic alopecia and parameters such as PSA level, IPSS, and prostate volume in men over 50.

This study found that patients with androgenetic alopecia had significantly higher COVID-19 severity compared to matched controls, suggesting a potential link between androgen pathways and disease severity. The authors suggest further research to validate this hypothesis and explore antiandrogen treatments for managing COVID-19 severity.

This study investigates the potential link between atrial fibrillation and circulating aldosterone levels related to cardiac fibrosis in patients with hypertension.